Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.6M Buy
+689,981
New +$83.5M 0.13% 127
2025
Q3
– Sell
-729,597
Closed -$73.4M – 3241
2025
Q2
$73.4M Buy
+729,597
New +$55.8M 0.32% 35
2024
Q2
– Sell
-24,944
Closed -$676K – 2621
2024
Q1
$676K Sell
24,944
-81,791
-77% -$2.29M ﹤0.01% 1095
2023
Q4
$3.31M Buy
+106,735
New +$2.77M 0.02% 445
2023
Q3
– Sell
-14,521
Closed -$306K – 2726
2023
Q2
$306K Buy
+14,521
New +$276K ﹤0.01% 1615
2022
Q4
– Sell
-33,945
Closed -$731K – 2780
2022
Q3
$731K Sell
33,945
-19,066
-36% -$457K 0.01% 1204
2022
Q2
$1.04M Buy
53,011
+42,347
+397% +$887K 0.01% 887
2022
Q1
$250K Buy
+10,664
New +$248K ﹤0.01% 2360
2020
Q4
– Sell
-38,036
Closed -$1.22M – 2132
2020
Q3
$1.22M Buy
+38,036
New +$1.09M 0.04% 418
2020
Q1
– Sell
-16,225
Closed -$387K – 1036
2019
Q4
$387K Buy
+16,225
New +$330K 0.02% 636

Other funds holding INSM

HRT Financial's INSM Position: Q2 2026 in Review

HRT Financial opened a new position in Insmed (INSM) in Q2 2026: 689,981 shares worth $73.6M. The stake represents 0.13% of the portfolio and ranks #127 among its holdings. This is a return to the name: HRT Financial previously reported a position in INSM as recently as Q2 2025.

HRT Financial first reported a position in INSM in Q4 2019 and has held it in 10 quarters since. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • HRT Financial held 689,981 shares of Insmed worth $73.6M as of Q2 2026.
  • Insmed was a new HRT Financial position in Q2 2026.
  • Insmed made up 0.13% of HRT Financial's portfolio in Q2 2026, its #127 holding.
  • HRT Financial first reported a position in Insmed in Q4 2019 and has held it in 10 quarters since.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.